Pernix Therapeutics Holdings Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
15,647.00
34,855.00
66,137.00
36,375.00
32,820.00
Total Accounts Receivable
30,430.80
48,850.00
67,944.00
52,143.00
45,440.00
Inventories
13,809.90
11,362.00
10,035.00
7,775.00
5,396.00
Other Current Assets
15,271.40
34,190.00
11,574.00
12,617.00
10,115.00
Total Current Assets
75,159.10
129,257.00
155,690.00
108,910.00
93,771.00
Net Property, Plant & Equipment
6,872.00
1,514.00
2,346.00
1,103.00
752.00
Long-Term Note Receivable
4,531.30
-
-
-
-
Intangible Assets
122,518.90
345,389.00
340,808.00
200,171.00
108,706.00
Other Assets
2,305.00
11,253.00
347.00
257.00
2,263.00
Total Assets
211,386.30
487,413.00
499,191.00
310,441.00
205,492.00
ST Debt & Current Portion LT Debt
16,999.70
7,345.00
13,335.00
11,103.00
3,664.00
Accounts Payable
3,443.60
5,399.00
14,081.00
7,275.00
7,911.00
Other Current Liabilities
49,024.30
84,933.00
105,027.00
91,150.00
82,226.00
Total Current Liabilities
69,467.70
97,677.00
132,443.00
109,528.00
93,801.00
Long-Term Debt
1,309.80
285,000.00
303,491.00
290,321.00
279,976.00
Provision for Risks & Charges
-
-
14,055.00
2,403.00
1,358.00
Deferred Taxes
15,499.00
9,389.00
202.00
-
-
Other Liabilities
14,387.80
11,755.00
15,903.00
22,252.00
4,614.00
Total Liabilities
100,664.20
403,821.00
466,094.00
424,504.00
379,749.00
Common Equity (Total)
110,722.10
83,592.00
33,097.00
114,063.00
174,257.00
Total Shareholders' Equity
110,722.10
83,592.00
33,097.00
114,063.00
174,257.00
Total Equity
110,722.10
83,592.00
33,097.00
114,063.00
174,257.00
Liabilities & Shareholders' Equity
211,386.30
487,413.00
499,191.00
310,441.00
205,492.00
About Pernix Therapeutics Holdings
View Profile
